Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 62.50
JAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 May 2022 10:27

RNS Number : 1108M
Mandarin Oriental International Ltd
19 May 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

19th May 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2022.

 

Trading conditions in the period improved in most parts of the world compared to the first quarter of 2021. Government restrictions on international and domestic travel, however, hampered the operating performance in Asia, with properties in China being particularly affected, and these challenges have continued into the second quarter.

 

In Europe, Middle East and Africa ('EMEA') and America, occupancy levels were lower than pre-pandemic levels for most properties, but room rates have held up well and are generally higher than in 2019. In Asia, both occupancy and room rates have remained substantially below pre-pandemic levels.

 

During the first quarter, the Group announced three new properties, in the Maldives, Costa Navarino and Cairo, increasing the Group's pipeline of new hotels and residences under development to 25.

 

The Group recorded an EBITDA loss of US$1 million in the first quarter. The impact of continued travel restrictions in much of Asia was offset by a more robust performance in EMEA and America and tightly-controlled corporate costs. Owned hotels and the management business recorded an underlying EBITDA loss of US$6 million and an underlying EBITDA profit of US$5 million, respectively.

 

Underlying losses (unaudited) for the Group were much improved compared to 2021, with the management business recording a marginal underlying profit (unaudited) in the period. As noted in the Group's 2021 full year results in March 2022, the outlook continues to improve in most markets, but there remains uncertainty in relation to China.

 

The Group's financial position is robust. Net debt at 31st March 2022 was US$542 million, and the Group held US$159 million of cash reserves and US$317 million in available, committed debt facilities. Gearing was 11% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley 

(852) 2895 9288

Matthew Bishop 

(852) 2895 9288

Brunswick Group Limited

Sunitha Chalam

(65) 6426 8188

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKKLBFLELLBBZ
Date   Source Headline
7th May 202412:27 pmRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 202411:52 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 202410:32 amRNSDividend
30th Apr 202411:27 amRNSTotal Voting Rights
30th Apr 202411:20 amRNSTransaction in Own Shares
30th Apr 202410:23 amRNSPT HERO SUPERMARKET TBK THREE MONTHS 2024 RESULTS
29th Apr 202412:19 pmRNSTransaction in Own Shares
29th Apr 202411:58 amRNSJC&C Interim Management Statement
29th Apr 202411:54 amRNSPT Astra 2024 First Quarter Financial Statements
26th Apr 202411:51 amRNSTransaction in Own Shares
26th Apr 202411:34 amRNSDividend
25th Apr 202411:51 amRNSTransaction in Own Shares
24th Apr 202411:56 amRNSTransaction in Own Shares
23rd Apr 202411:47 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 202412:44 pmRNSTransaction in Own Shares
18th Apr 202412:34 pmRNSTransaction in Own Shares
17th Apr 202411:29 amRNSTransaction in Own Shares
16th Apr 20241:23 pmRNSTransaction in Own Shares
15th Apr 202411:47 amRNSTransaction in Own Shares
12th Apr 202411:07 amRNSTransaction in Own Shares
9th Apr 202411:17 amRNSTransaction in Own Shares
9th Apr 202410:22 amRNSAnnual Financial Report
5th Apr 202411:59 amRNSTransaction in Own Shares
3rd Apr 20243:48 pmRNSTransaction in Own Shares
3rd Apr 202410:33 amRNSCirc re. Scrip Dividend Scheme
2nd Apr 202411:53 amRNSTransaction in Own Shares
28th Mar 202411:04 amRNSTotal Voting Rights
28th Mar 202410:56 amRNSTransaction in Own Shares
27th Mar 202410:11 amRNSTransaction in Own Shares
26th Mar 20241:24 pmRNSTransaction in Own Shares
25th Mar 20242:13 pmRNSTransaction in Own Shares
25th Mar 202410:23 amRNSBlock listing Interim Review
22nd Mar 202411:34 amRNSTransaction in Own Shares
21st Mar 202411:06 amRNSTransaction in Own Shares
19th Mar 20249:49 amRNSDirector/PDMR Shareholding
13th Mar 202411:21 amRNSTransaction in Own Shares
13th Mar 20248:59 amRNSPT HERO SUPERMARKET TBK FULL YEAR 2023 RESULTS
12th Mar 202410:08 amRNSDirector/PDMR Shareholding
12th Mar 20249:57 amRNSCorrection: Director/PDMR Shareholding
11th Mar 202410:15 amRNSTransaction in Own Shares
7th Mar 202412:21 pmRNS2023 Preliminary Results
7th Mar 202412:02 pmRNS2023 Preliminary Results
7th Mar 202411:01 amRNS2023 Preliminary Results
7th Mar 202410:04 amRNS2023 Preliminary Results
1st Mar 202410:14 amRNSChange of Singapore Branch Registrar
29th Feb 202410:54 amRNSTotal Voting Rights
27th Feb 202410:54 amRNSJC&C - 2023 FY Results and Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.